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Inhibition  of  the  mitotic reaction of lymphocytes to phytohemagglutinin 
(PHA)  by certain species of mycoplasmas was described by Copperman and 
Morton  (1).  These  investigators  showed  that  suspensions  of  whole  myco- 
plasmas, as well as aqueous extracts of frozen-thawed organisms (2), prevented 
the reaction while in contact with the cells; reactivity was restored when the 
lymphocytes were washed. 
In view of the ubiquity of mycoplasmas as contaminants of most tissue cul- 
ture lines, as well as the possibility that these agents may play roles still un- 
recognized in the pathogenesis of disease, it is of importance to determine the 
mechanism underlying this phenomenon. Recent reports have suggested that 
the mycoplasmas inhibit lymphocyte transformation by competitive metabo- 
lism of arginine (3, 4, 5). 
The present report presents additional evidence that the arg~nlne dihydrolase 
enzyme system of mycoplasmas is  responsible for lymphocyte inhibition.  It 
will also be shown that the response of lymphocytes to antigenic st/mulation is 
similarly inhibited, and the in vitro production of antibody by lymph node ex- 
plants is prevented. 
Material and Methods 
Preparation of Mycoplasmal Extta~t.--Mycoplasmas  were grown at 37°C in broth media,  as 
previously described (6), supplemented with 0.5% arginine or 0.5% glucose. Titers of the 
organisms at the time of harvest were generally 10  ° CFU/ml. The mycoplasmas  were sedi- 
mented by centrifugation and washed three times in 0.85% NaCI. They were then suspended 
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to a volume ~oth of the original broth in distilled water and disrupted by 20 cycles of freezing 
and thawing in a dry ice-acetone bath which resulted in the killing of all organisms. The cell 
membranes of the disrupted organisms were removed by centrifugation at 30,000 g, and the 
aqueous supernatant (50 X) was diluted in tissue culture medium to 1 X  prior to addition to 
cultures, unless otherwise indicated. 
Lymphocytes.--Cultures  of  human  lymphocytes  were  prepared  from  heparinized  blood 
drawn by aseptic venipuncture. The blood was allowed to stand at 37°C for 1-2 hr before the 
leukocyte-rich plasma was collected. The lymphocytes were separated by passage of the plasma 
through a glass wool column which restrained most of the other nucleated cells (7). The lym- 
phocytes were washed and suspended in Eagle's minimal essential medium (MEM), containing 
2 m~ L-giutamine, 100 units of penicillin, and 100 ~g streptomycin/ml with 20% autologous 
plasma. The concentration of cells was adjusted to 0.5-0.75 X  106/ml and the suspension was 
dispensed in 4 ml aliquots in sterile 16 X  125 mm culture tubes. 
Mitotic stimulus to the lymphocytes was provided by the addition of PHA, tuberculin, or 
by the "mixed lymphocyte reaction" (8). Phytohemagglutinin (PHA-M, Difco Laboratories, 
Detroit, Mich.), 0.1 ml, was added to appropriate tubes. Tuberculin (PPD), Parke, Davis & 
Co., Detroit, Mich), 5 vg, was added to lymphoeytes of a tuberculin-sensitive donor. The mixed 
lymphocyte reaction was carried out by combining 2 ml cell suspensions for two donors. Myco- 
plasmal extract, 0.1 ml, was then added, and the tubes were gassed with 5% CO~-air incubated 
at 37°C. 
Lymphocytic response to  these stimuli was determined by incorporation of 14C-labeled 
thymidine (9) and by morphological criteria. 24 hr prior to harvesting, 0.1 vc of z4C-thymidine 
(specific activity 54.1 mc/mmole) was added to triplicate tubes. At the end of the incubation 
period, the cells were sedimented, washed once with 0.85% NaCI, twice with cold trichloro- 
acetic acid, and twice with cold methanol. The material was then dried at room temperature 
overnight, dissolved in Hyamine (Packard Instrument Co., Downers Grove, Ill.), and trans- 
ferred to vials containing Liquifluor  (Packard)  in toluene. Radioactivity was counted in a 
Packard Tri-Carb scintillation counter. 
Cells from duplicate tubes without labeled thymidine were harvested at the same  time, 
spread on coverslips, and stained with acetic orcein. Cell viability was determined by exclusion 
of trypan blue. 
Antibody  Format~ in  Vitro.--Adult  male  New  Zealand white rabbits were immunized 
with a  single dose of 2  X  200 Lf diphtheria toxoid  (DT, Lederle Laboratories,  Pearl River, 
N. Y.), injected into the hind footpads. Popliteal lymph nodes from these animals were re- 
moved for tissue culture 2 months or longer after immunization. 
The in vitro production of antibody was investigated as previously described  (10,  11). 
Approximately 20 mg of i-2 mm lymph node fragments was distributed over the walls of 16 X 
125 mm screw-capped roller tubes. Each tube received 1 ml of MEM containing 25% normal 
rabbit serum. Within each experiment, duplicate tubes received similar additions of antigen 
(1 Lf DT)  and mycoplasma  (0.05  ml of 1  X  or 50 X  concentrated extract).  Antigen was 
left with the tissue for the initial 7-8 hr of culture, and then rinsed off with Hanks' basic saline 
solution (BSS). The medium was changed every 3 days and the cultures were maintained from 
12-18 days. In some experiments, the tissue was exposed to 1*C-amino acid as described below. 
_Protein Production by Other Cell Types.--The parenchymal type hepatoma cell line H411- 
E¢3 (12) was grown on the wall of 15 ml plastic culture flasks in Dulbecco's medium. Cells from 
a line derived from a  human lymph node,  SK-LN-1  (13), were grown in modified McCoy's 
medium (Grand Island Biological Co., Grand Island, N. Y.) containing 15% fetal calf serum. 
Mycoplasmal extract (0.2 ml per 5 ml medium) was added and left for 24 or 48 hr with these 
cells before their exposure to medium containing 1*C-amino acids. 
In order to study serum protein synthesis, the cells were incubated at 37°C for 24 hr in ~.  s.  s~xggo~T,  G.  j.  THORBZCKE, AND L.  XEO~AS  1165 
modified MEM  containing 1~C-labeled lysine (1 ttc/ml) and isoleucine (1 uc/ml) of  specific 
activity 100-200 mc/mmole. The culture fluids were dialyzed, lyophili~.ed, and redissolved for 
characterization by immunoelectrophoresis (IE) and radioantography as described elsewhere 
(14). 
This method can also be used for the demonstration of antibody synthesis and differentiates 
between release of intracellularly stored antibody and synthesis (14). The "cartier-system" in 
the IE patterns  consisted in such cases of an antigen-antibody precipitation arc made by 
precipitation of strong anti-DT, after subjection to electrophoresis, by dilute DT. 
Antibody Formation  In Vivo.--Mycoplasmal  extract was injected into adult Sprague-Dawley 
rats and Swiss albino mice according to a variety of schedules. Sera were obtained from these 
animals 5-7 days after the intravenous injection of sheep red blood cens. Hemagglutinin titers 
of the sera, inactivated at 56°C, were measured by microtiter. 
RESULTS 
The Effect of Various Mycoplasmas on Lymphocyte  Reactivity.--The effect of 
10 species of mycoplasma on the response of lymphocytes is shown in Table I. 
Suspensions of mycoplasmas, killed by freeze-thawing, were added to lympho- 
cyte cultures stimulated with PHA. Five of these completely inhibited incor- 
poration of labeled nucleotide into the lymphocytes. Comparable extracts of 
the remaining five had no effect. 
Arginine is known to serve as an important source of energy for certain species 
of mycoplasma through the arginine dihydrolase enzyme system (15). Five of 
the strains studied utilize arginine in this way; five do not. It was found that the 
capacity to inhibit lymphocyte responsiveness was correlated in each instance 
with the requirement for supplemental  arginine, as is indicated in Table L  In 
each case, inhibition of nucleotide uptake was accompanied by complete sup- 
pression of mitosis and transformation to blast cells, estimated by direct exami- 
nation of Giemsa-stained films. 
The viability of lymphocytes was  not affected by any of the mycoplasmas 
tested as judged  by morphological study of stained smears and by the exclusion 
of trypan blue in fresh preparations. 
Properties  of the Inhibitory Extract.--Extracts  from Mycoplasma artkritidis 
were prepared and treated in a  variety of ways in an attempt to purify the 
lymphocyte inhibiting factor. The results are shown in Table II. The superna- 
rant  fraction  of freeze-thaw disrupted  organisms centrifuged  at  30,000  g  or 
150,000  g inhibited lymphocytes, indicating that the factor was not associated 
with the antigenic membrane of the mycoplasma (16)  nor with its ribosomal 
fraction (17). Dialysis of the 30,000 g supematant against saline and extraction 
three times with cold ether did not diminish its inhibitory capacity. When the 
superuatant was heated at 56°C for 2 hr, however, it was no longer inhibitory. 
Trypsin did not affect the extract, but treatment with cysteine-activated papain 
at 37°C for 2 hr destroyed all activity. Nonactivated papain had no effect on 
the system. The results suggest that the active portion of the mycoplasma ex- 
tract is a nondialyzable, heat-labile protein. 1166  STUDIES  OF  PPLO  INYECTION.  V 
TABLE I 
Effect of Various  Species  of Mycoplasraa  on the Lymphocyte  Response  to PttA 
Species 
M. arthritidis 
M. hominis 1 
M. orale I 
M. orale II 
M. scdivarium 
M. pneumoniae 
M. gallisepticum 
M. pulmonis 
M. neurolyticum 
M. fermentans 
Arginine 
metabolism 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
No 
No 
No 
No 
l~C-thymidine  incorporated* 
Control:[  +  Mycoplasma| 
cpm  cpm 
16,622  25 
16,622  75 
11,649  11 
11,497  35 
11,649  465 
16,573  14,140 
16,622  14,846 
16,573  13 ~  980 
16,622  10,757 
8,771  7,281 
Inhibition of 
mitosis and 
Lransformation[[ 
++++ 
++++ 
++++ 
++++ 
++++ 
0 
0 
0 
0 
0 
* By lymphocytes during the final 24 hr of a 72 hr incubation period. The results are the 
average of triplicate samples. 
Control human lymphocyte cultures contain approximately 2 million cells in 4  ml me- 
dium (MEM with 20% autologous plasma) and 0.1 ml PHA-M. 
§ 0.1 ml of the freeze-thaw disrupted organisms added  to cultures otherwise identical to 
control. 
[l Inhibition  of  morphological  transformation  of  cells compared  to  controls.  ++++ 
denotes complete inhibition, while 0 denotes no inhibition. 
TABLE II 
Effect of Extracts from M. arthritidis,  Prepared  in  Various  Ways, on Lymphocyte  Response  to 
PttA 
Extract treatment 
M. arthritidis,  freeze-thawed 
Superuatant, 30,000 g 
"  150,000 g 
"  30,000 g, dialyzed 
"  heated 56°C, 2 hr 
"  either extracted [[ 
"  papain treated ¶ 
t*C-thymldine incorporated* 
Controls  +  Extract§ 
cpm  cpr~ 
16,622  25 
16,238  4 
20,582  1 
16,238  10 
33,424  23,728 
33,725  6 
14,516  15,047 
* Mitotic activity of lymphocytes during the final 24 hr of a 72 hr incubation period. 
Control human  lymphocyte cultures contain approximately 2 million cells in 4  ml of 
medium and 0.1 ml PHA-M. 
§ 0.1 ml of organism or extract treated as indicated added to cultures otherwise identical 
with control. 
[1 Aqueous material extracted three times with equal volumes of cold diethyl ether. 
¶  Mycoplssmal extract was treated with 0.5 mg/ml cysteine activated crystallized papain, 
37°C for 2 hr. The papain was then inactivated by dialysis of the solution. M.  S.  S  rM~ERKO~T,  O.  J.  THORBECKE,  AND  L.  THOMAS  1167 
Reversibility of the Effect of Mycoplasmal ExtracL--The  response of lympho- 
cytes to PHA is the result of binding between PHA and receptors on the cell 
surface (18). The mycoplasmal extract did not interfere with this process. Cells 
exposed to PHA and extract, and then washed, subsequently underwent blast 
transformation without additional PHA (Table III). 
Removal of the extract by washing permitted the lymphocytes to regain re- 
sponsiveness to PHA, although their capacity to incorporate thymidine was 
somewhat less than that of untreated controls. As is also shown in Table III, 
cells treated in the first 24 hr with extract were less reactive to PHA added after 
this time. The spontaneous activity of ceils, as indicated by the incorporation of 
nucleotlde in the absence of PHA, was also suppressed by the extract. 
TABLE HI 
Reversib4lity of Inhibition of the Lymphocyte Response* to PHA by M. arthritidis Extract 
Additives to initial medium 
None 
PHA§ 
Extract[[ 
PHA +  Extract 
Additives to medium after change st 24 hr$ 
None 
182 
32,305 
91 
21,942 
PHM 
18,687 
24,255 
9,949 
15,014 
ExtractU  PHA +  Extract 
9  2 
110  87 
19  0 
19  11 
* Mitotic activity of lymphocytes expressed as cpm t4C-thymidine incorporated during 
the final 24 hr of a 96 hr incubation period. 
24 hr after initiation of the culture, medium was removed, the cells were washed and 
resuspended in fresh medium with additives as indicated. 
§ PHA-M, 0.1 ml added to each tube. 
It Extract, 0.1 ml of the 30,000 g supernatant of freeze-thaw  disrupted mycoplasrna  added 
to each tube. 
Although the addition of mycoplasmal extract to lymphocyte cultures 24 hr 
after stimulation seemed to block subsequent mitotic activity, it was of interest 
to determine whether this effect would be noted after the appearance of mor- 
phologically transformed cells in the cultures (19). Fig. 1 shows the results of an 
experiment in which the extract was added to lymphocyte cultures 3 days after 
stimulation with PHA. Although nucleotide incorporation dropped to about 
25 %  of the control value, it nonetheless continued at a  significant rate, and, 
within another 3 days, was again increasing. 
Effect of A rginine on Mycoplasmal Extraa.--The  observation that inhibition 
by the factor was correlated with the property of arginlne utilization by certain 
mycoplasma species suggested that the inhibitor might be an enzyme involved 
in the metabolism of this amino acid. To explore this possibility, the effect of 
supplemental arginine on lymphocytes treated with PHA extract was investi- 
gated. The results are shown in Table IV. 1168  STUDIES  OF  PPLO INFECTION.  V 
MEM contains 10.5 mg% arginine and, in addition, this amino acid is a constit- 
uent of plasma. The addition of excess arginine, as seen in Table IV,  caused 
reversal of the inhibitory effect of mycoplasmal extract. The mounts of argi- 
nine required to reverse inhibition varied with the concentration of extract era- 
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FIc.  1.  Mitotic activity of lymphocytes expressed  as cpm 14C-thymidine incorporated dur- 
ing the 24 hr period prior to harvesting of the cells on the day indicated. PHA-M, 0.1 ml was 
added to the tubes indicated at the initiation of the culture, while M. arthr~  extract, 0.1 
ml of the I  X  solution, was added to the tubes indicated at the start or on day 3 of incubation. 
TABLE IV 
Effect of Arginine and  Citrulline  on Inhibition  of Lymphocyte  Response*  to PHA by 
M. arthritidis  Extract 
Extract added to medium 
None 
0.1ml,  I  X  concentrated 
0.1ml, I/~ X  concentrated 
0. i  ml, ~o  X  concentrated 
None 
13,399 
9 
3 
247 
Supplements  to Medium 
Arginine 
20 mg 
12,095 
1,582 
11,159 
10,029 
Ar~nme 
lOmg 
--§ 
62 
15,436 
16,639 
Arginine 
5mg 
4,384 
15,280 
Citrulline 
20 mg 
8,927 
8 
* Mitotic activity expressed as cpm 14C-thymidine incorporated into lymphocytes during 
final 24 hr of 72 hr incubation period. PHA-M, 0.1 ml was added to each tube. 
Extract, arginine, and citmlline are given as total amount added to 4 ml of cell suspension. 
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ployed. Citrulline is the first product of the arginine dihydrolase system (15). 
When this amino acid was tested in a similar range of concentrations,  no effect 
was noted. 
In order to learn whether the extract acted primarily on the medium or the 
lymphocytes themselves, experiments were performed with medium which had 
been pretreated with M. arthrilidis extract and then heated to destroy enzyme 
activity. As is shown in Table V, lymphocytes were unable to respond to PHA 
when suspended in such medium, but the addition of arginine caused complete 
restoration  of  the  response.  At  the  concentration  used,  arginine  had  no  in- 
fluence on the inhibition produced by active extract. 
TABLE V 
Effect of Preincubation of Medium with M. arthritidis Extract on Lymphocyte Res ~onse* to PHA 
Treatment of medium~  Added with lmphocytes  No arginine§  Arginine, 1 mg  to medium 
Preincubated alone  11  13 
'reincubated with active extract, then 
56°C, 2 hr 
~eincubated with heat-inactivated ¶ 
extract 
PHA +  active 
extract 
PHA 
PHA 
36 
11,649 
9,302 
9,698 
* Mitotic activity expressed as cpm x4C-thymidine incorporated by lymphocytes during 
final 24 hr of 72 hr incubation period. 
:~ Media were preincubated at 37°C for 24 hr with or without M. arthritidis extract  as 
indicated and then heated at 56°C for 2 hr prior to addition of lymphocytes. 
§ Arginine, total amount added to 4 ml cell suspension. 
[l Extract,  0.1 ml, 30,000 g supernatant  added per 4 ml medium as indicated.  PHA-M, 
0.1 ml added per tube with lymphocytes. 
¶ Extract heated 56°C for 2 hr prior to preincubation with medium. 
M. arthritidis,  1  X  concentrated, contained 0.133 IU of arginine deiminase 
(assayed by M. I. Rothman and Dr. J. D. Broome). Further evidence that the 
inhibitory effect on lymphocytes is due to the action of this enzyme was ob- 
tained in experiments with an arginine  deiminase derived from Streptococcus 
faecalis (20). In concentrations of 0.016 IU/tube or higher, this enzyme caused 
complete inhibition of the response of human lymphocytes to PHA. 
Antigenicity of the Mycoplasmal Extract.--Sera from rabbits immunized with 
various mycoplasmas, as previously described (21), were tested for their effect 
on the extract in lymphocyte cultures. In these experiments, 0.1 ml amounts of 
extract and 0.1 ml of 1:5 dilutions of the sera were added to lymphocyte cul- 
tures stimulated with PHA. Sera from two rabbits immunized with M. artkri- 1170  STUDIES OF  PPLO INYECTION. V 
tidis reversed the effect of extracts of that organism on the lymphocytes. These 
sera also blocked the effects of extracts prepared from M. hominis I, M. orale I, 
M.  orale  II,  and M.  salivarium.  Sera from  two  rabbits immunized  with  M. 
gallisepticum,  an organism which does not metabolize arginine, did not reverse 
inhibition. It is of interest that none of these sera blocked the effects of the 
streptococcal enzyme on the stimulated lymphocytes. 
TABLE VI 
Effect of L-Cana~anine on Lymphocyte Response* to PHA and Reversal by Arginine 
Canavanine addedt 
None 
5 nag 
2.5 mg 
1.25 mg 
None 
3,665 
30 
424 
1,902 
Arginlne  added~ 
5mg  lmg 
2,227  3,903 
1,000  899 
2,731  2,333 
3,111  3,017 
0.5 nag 
q 
278 
1,428 
2,874 
* Mitotic activity expressed as cpm 14C-thymidine incorporated during the last 24 hr of a 
72 hr incubation period. Control and test lymphocyte cultures contained 0.1 ml of PHA-M. 
Total amount added to 4 ml of lymphocyte culture medium. 
TABLE VII 
Effect of M. arthritidis Extract on A ntigonic Stimulation  of Lymphocytes 
Incubated lymphocytes 
PPD-sensitive cells without PPD 
PPD-sensitive cells with PPD, 5-#g 
Cells of K. S. and E. B. separately 
Cells of K. S. and E. B. § mixed 
l*C-thymldine  incorporated* 
No extract added  Extract  added~ 
cpm 
60 
4,067 
203 
2,316 
c~n 
18 
11 
8 
4 
* 14C-thymidine incorporated during the final 24 hr of 120 hr incubation period. Cultures 
contained 2 million cells in 4 ml medium. 
$ Extract, 0.1 ml, 30,000 g supernatant freeze-thaw disrupted mycoplasma. 
§ 1 million cells from each donor, K. S. and E. B., added to final 4 ml incubation mixture. 
The  Effect  of L-Canavanine  on  Lymphocyte  Reaction.--z-canavaniue,  an 
analogue of arginine, has been shown to inhibit competitively the growth and 
metabolism of bacteria (22) and a number of human cell cultures in vitro (23). 
It was therefore of interest to determine its effect on PHA-stimulated lympho- 
cytes.  The  results  are  shown  in  Table  VI.  5  mg  of  canavanine  completely 
blocked thymidine incorporation by lymphocytes while smaller amounts caused M.  S. SrafRERKOFF, O.  J.  THORBECKE,  AND  L.  THOMAS  1171 
partial inhibition. Supplementation of the medium with arginine resulted in a 
competitive reversal of the inhibition. 
The Effect of Mycoplasmal Extract on Immunologically Stimulated Lympho- 
cytes.--The in vitro response of lymphocytes from immunized donors to contact 
with specific antigens resembles the reactions of these ceils  to PHA (24); the 
cells undergo mitotic transformation to blast forms and the uptake of nucleo- 
tides is correspondingly stimulated.  In order to learn whether this  reaction is 
inhibited  by the  mycoplasmal extract,  the  following experiments  were  per- 
formed. 
TABLE VIII 
Effect of M. arthritidis Extract on the Secondary Immune  Response to Diptheria  Toxoid by 
Rabbit Lymph Nodes in Vitro 
Exposure to extract* 
None 
Throughout, 1 X concentrated 
Throughout, 50 X concentrated 
First 24hr  "  "  " 
First 3 days  "  "  " 
First 6 days  "  "  " 
First 9 days  "  "  " 
None 
None 
First 6 days  "  "  " 
Ds~ of 
antigen 
addition 
0 
0 
0 
0 
0 
0 
0 
3 
6 
6 
Reciprocal of peak titer$ 
Exp. IV  Exp. I  Exp. II  Exp.  III 
16,000  32,000  24,000 
1,000 
<2  <2 
24,000  24,000 
2,000  8,000 
4,000 
96.000 
<2 
4,000 
4,000 
4,000 
48 
1,500 
* 0.5 ml of varying concentrations of 30,000 g supematant, freeze-thaw disrupted organ- 
isms. 
:~ Passive hemagglufinin titer of third medium change after addition of 1 Lf DT left for 
7 hr with lymph node fragments at initiation of cultures. Medium was changed every 3 days. 
Lymphocytes  from tuberculin-sensitive donors were cultured in medium con- 
taining tuberculin (PPD) and M. arthritidis extract was added. The results  are 
shown in Table VII. 
Lymphocytes from unrelated donors were combined in approximately equal 
numbers and cultured; the mitotic response of such mixed cell populations has 
been shown to be a  reflection of homograft incomparability (25).  The effect of 
M. arthritidis extract on this reaction is also shown in Table VII. 
Both the in vitro reaction to tuberculin and the mixed lymphocyte reaction 
were completely inhibited by the addition of this extract. 
The Effect of Mycoplasmal Extract on the Secondary Immune Response in Vitro. 
--Lymph node explants from rabbits previously immunized against diphtheria 
toxoid were found to produce antibody in vitro within 6 days after exposure to 1172  STUDIES  O~"  PPLO  IN]~ECTION.  V 
antigen in titers ranging from 1:2,000 to 1:32,000. Peak titers were usually en- 
countered on the 9th day of culture,  and antibody continued through at least 
the 15th day. 
M. arthriE~d~s extract completely prevented the production of antibody when 
present throughout the period of culture. The results of an illustrative experi- 
ment are shown in Table VIII. It was noted that explants cultured with myco- 
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FIG. 2.  Secondary immune response to diphtheria toxoid by rabbit lymph node fragments 
expressed as the reciprocal of passive hemagglutinin titers of media changes. After the second 
medium change, the experimental tubes received 0.05 ml of a 50-fold concentrated, 30,000 g 
supernatant, freeze-thaw disrupted mycoplasma extract at each subsequent medium change. 
plasmal extract showed little or no evidence of proliferation at the periphery 
when compared with controls. Extracts of M. twminis I had the same inhibitory 
action  on  antibody  formation and  cell proliferation,  while  an extract  of M. 
gallisepticum  (which had been shown to be without effect on the PHA response) 
caused no inhibition. 
Removal of the mycoplasmal extract, by changing the medium in which the 
explants  were  cultured,  resulted  in  prompt  antibody production,  indicating 
that the extract did not interfere with the initial reaction between antigen and M.  S.  SIMBERKOFF,  G.  J.  THORBECKE,  AND  L.  THOMAS  1173 
FIG.  3.  Radioautograms (RA) of immunoelectrophoretic (IE)  patterns  (bottom)  prepared 
with culture fluids from lymph node fragments. The tissues were grown for 13 days after in- 
duction of a  secondary response to diphtheria toxoid  (DT)  in minimal Eagle's medium with 
20% normal rabbit serum. To some tubes, 0.05 ml of 50 X  concentrated M. arthritidis  extract 
(MYC)  per ml was added, either for the first 6  days only, or for the full 13  days. The 14C- 
amino acid  containing medium was then left with  the tissue for 24 hr.  The carrier patterns 
were developed from rabbit antiserum to DT  (RAT) with a  sheep antiserum to rabbit serum 
(anti-rabbit)  or with DT.  Note strong labeling of 7-globulin  (IgG)  in all cultures except the 
one left with M. arthrltldls extract for the full 13 days, and labeling of antibody  after  exposure 
to DT only when the tissues were left for 7 or 13 days in the absence of the M. arthritidis ex- 
tract. 1174  STUDIES  OF  PPLO  INFECTION.  V 
FIG. 4.  Radioautograms (RA) of immunoelectrophoretic (IE)  patterns  (bottom)  prepared 
with culture fluids from rat hepatoma cell line, H411-Ec3. The cells were grown in Dulbecco's 
medium in the presence of 0.05 ml of a  50 >(  concentrated M. arthrltidis extract  (MY'C) per 
ml of medium for 48 hr prior  to  addition  of the 14C-amino acid-containing medium with  a 
similar M. arthrltldis extract concentration for an additional 24 hr. Carrier patterns were de- 
veloped from undiluted or 1:4 diluted rat serum (RS) by two different rabbit antisera to whole 
rat serum (anti-rat). Note identical labeling of a variety of serum proteins in cultures regardless 
of exposure to M.  c~rthritidls  extract. M.  S.  SIMBERKOFF,  G.  J.  THORBECKE,  AND  L.  THOMAS  1175 
cell receptors. Explants held in a state of inhibition for periods as long as 9 days 
remained capable of producing antibody once  the  extract was removed. 
Addition of  1  mg  of canavanine per milliliter at  each medium  change  also 
markedly diminished antibody production  in  these  cultures.  Removal  of  the 
canavanine,  however,  did  not  result  in  recovery  of  the  antibody  formation. 
FIG. 5.  Radioautograms (RA) of immunoelectrophoretic  (IE) patterns (bottom)  prepared 
with culture fluids from human lymphoid cell line, SK-LN-1. The cells were grown in McCoy's 
medium in the presence of 0.05 ml of a 50 )< concentrated M. arthritidis (MYC) extract per ml 
of medium for 24 hr and were then left with the ~4C-amino acid-containing medium with a 
similar M. arthritidls extract concentration for an additional 24 hr. Carrier patterns were de- 
veloped from whole human serum (HuS) with rabbit antiserum to whole human serum  (anti- 
human). Note slight reduction in labeling of IgG in cultures 3 and 4, containing M. arthritidis 
extract, as compared to control cultures 1 and 2. Cultures 2 and 4 contained three times the 
number of cells contained in cultures 1 and 3 during the period of exposure to 14C-amino acid. 
It will be noted in Table VIII that control explants, not exposed to antigen, 
produced low levels of antibody throughout the period of incubation, and that 
this  spontaneous  activity was  also inhibited  by mycoplasmal extract.  When 
tissues were treated with extract for 6  days, and then washed and exposed to 
antigen, their capacity to produce antibody was significantly greater than that 
of control cells. 
Although mycoplasmal extract prevented the initiation of antibody produc- 
tion, it was not capable of shutting off production when it had already begun. 1176  STUDIES  OF PPLO  INFECTION.  V 
This point is illustrated in Fig. 2. When explants were exposed to antigen and 
then cultured for 6 days before the addition of extract, antibody continued to be 
formed during the following 9 days. The level of antibody did not increase after 
the 6th day, as did the control, and the rate of decline after the 9th day was 
greater, but it was clear that the explants continued to produce antibody despite 
the presence of mycoplasmal extract. The results were in sharp contrast to the 
total inhibition seen when the extract was introduced simultaneously with the 
antigen. 
The Effect of Mycoplasmal Extract on Protein Production in Vitro --Although 
radioautography and immunoelectrophoresis patterns do not provide a quanti- 
tative measure of serum protein production, previous studies have shown it can 
be used for semiquantitative comparisons between levels of serum protein syn- 
thesis in different tissues (14). Incorporation of 1*C-amino acids into 3,-globulin 
normally occurs in the lymph node fragments used for these studies throughout 
the period of observation. Although exposure to antigen enhances this produc- 
tion somewhat in the sensitized tissue, 3,-glebulin formation also occurs in the 
absence of antigenic exposure. Fig. 3 illustrates the production of IgG and anti- 
body in lymph node fragments during the 13th day after initiation of the cul- 
ture. It can be seen that the presence of mycoplasmal extract for 6 days from 
the outset of the culture period did not affect the final levels of IgG or antibody 
production, while the continuous presence of the extract not only eliminated 
antibody synthesis, but also greatly reduced the IgG synthesis. 
Production of serum proteins, including albumin, transferrin, and various 
and B-globulins by the rat hepatoma line, H411-Ec3 (26), was not significantly 
affected by the extract. Even after growing for 48 hr in the presence of extract 
concentrations which completely inhibited induction of a secondary response in 
lymph node fragments, these parenchymal type liver cells actively incorporated 
14C-amino acids into serum proteins (Fig. 4). The growth rate of these cells was 
also unaffected by the mycoplasmal extract over a period of 48 hr. 
The human lymphoid cells, SK-LN-1, grown as a continuous suspension cul- 
ture, continues to form immune globulins, although at a slightly reduced level, 
during and after exposure to M. arthritidis extract (Fig. 5). 
The E~ect of Mycoplasmal Extract on  Antibody Production in Vivo.--In view 
of the  capacity of mycoplasmal extracts to suppress  antibody production in 
vitro, experiments were designed to determine whether comparable effects could 
be obtained in live animals. Rats and mice were given daily injections, by intra- 
venous or intraperitoneal routes, of 0.1-0.5 ml of the 50 X  M. arthritidis ex- 
tract. A  suspension of sheep erythrocytes was injected by vein after the first 
injection of extract, and the levels of hemagglutinating antibody were deter- 
mined on the 7th day. No inhibition of antibody formation was demonstrable 
under these conditions. 
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by these findings was that the arginase enzyme uniquely affects lymphocytic 
responsiveness.  The  effects of L-asparaginase  on  these  cells  was  therefore 
studied. The results with two enzyme preparations, Escherickia coli and agoufi 
serum are shown in Table IX. While the E. coli enzyme completely inhibited 
the incorporation of thymidine into PHA-stimulated lymphocytes and antibody 
production in vitro, comparable amounts of agoufi serum were ineffective. It is 
known that while the agouti serum asparaginase is highly specific, the E. coli 
enzyme is also capable of degrading glutamine (27). It is possible that this ac- 
counts for the difference between the two preparations. In fact, addition of both 
TABLE  IX 
Effect of "Asparaginase"  on Lymphocyte Response* to PHA and Secondary Antibody Response~ 
in Vitro 
q- Test  Inhibition 
secondary  Added test material§  Control  material  antibody responseU 
Asparaginase,  1 IU¶ 
Asparaginase, 5 IU 
Asparaginase, 10 IU 
Agouti serum, 2.5 IU 
9,682 
15,105 
9,682 
5,112 
cpm 
566 
12 
7 
1,242 
++ 
+++ 
0 
* Mitotic activity expressed as cpm 14C-thymidine  incorporated during the last 24 hr of a 
72 hr incubation period. Control and test lymphocyte  culture tubes contained 0.1 ml PHA-M. 
Anti-diphtheria toxoid response by sensitized rabbit lymph node fragments after ex- 
posure to DT in vitro. 
§ Total mounts added to 4 ml culture medium for human lymphocytes. 
[] Results expressed as comparison to control cultures. +++  denotes virtually complete 
suppression; 0, negligible suppression of antibody formation. The E. ¢oli asparaginase (1 or 
10 IU/ml) or agouti serum (1 IU/ml medium) was added with each medium change. 
¶ Asparaginase (Sigma Chemical Co., St. Louis, Mo). purified from g.. coli 30 IU/mg. 
L-asparagine and L-glutamine to the medium along with the E. coli enzyme did 
not reverse its effect. As with the mycoplasmal extract, complete reversibility of 
inhibition by washing and medium change was demonstrated. Supplementation 
of the medium with arginine, however, did not reverse its effect. Thus, this en- 
zyme, which does not affect arginine metabolism, dearly affects lymphocytic 
reactivity, although  the mechanism  of its action remains  to be determined. 
DISCUSSION" 
The present study indicates that extracts of certain mycoplasma inhibit the 
proliferative response of lymphocytes to a variety of stimuli. In addition to pre- 
venting PHA-induced blast transformation, as described earlier by Copperman 
and Morton (2), these extracts also block the response of sensitized lympho- 
cytes to tuberculin and homograft antigens, and the secondary production of 1178  STUDIES  OF  PPLO  INFECTION.  V 
antibody to diphtheria toxoid in vitro. The mechanism of all these effects is 
probably through inhibition of blast cell transformation and, consequently, of 
proliferation.  Agents which inhibit cell proliferation,  such as BUDR (5-bromo- 
deoxyuridine), are known to inhibit the secondary immune response  in vitro 
when applied during the first few days after exposure of tissue to antigen (28). 
Mycoplasma extract must be present throughout the cell incubation period to 
prevent lymphocytic transformation or the secondary antibody response. If the 
extract is removed after 24 hr, thymidine incorporation in lymphocytes stimu- 
lated with PHA is almost completely restored. The fact that restoration was 
usually partial could be due to slight toxicity of the extract for lymphocytes, al- 
though viable cell counts with trypan blue gave no  evidence for toxicity. A 
better explanation may be that the cells treated with extract and PI-IA for the 
first 24 hr are simply deprived of this period of PHA-stimulated activity, and 
have, therefore,  a shorter total time for the cumulative response  to PHA. 
No evidence  of  any  toxicity of the  mycoplasma extract  on lymph  node 
fragments has  been obtained from the studies on antibody formation,  even 
though  concentration  of  the  extract  used was  considerably higher  than  in 
peripheral lymphocyte experiments. On the contrary, preservation of immune 
responsiveness was noted in lymph node cultures incubated in the presence of 
mycoplasmal extract during a  6 day period prior to addition of the antigen. 
Comparable cultures held for this period without extract are capable of only a 
very low antibody response  upon addition  of antigen  on the 6th  day. The 
extract may have preserved the reactivity of the tissue by preventing spon- 
taneous blast formation and  dedifferentiation  of the  "memory" ceils  in  the 
lymph node fragments. 
A number of findings support the view that the active portion of the myco- 
plasmal extract is a protein. It is present in the supernatant fraction of 150,000 
g centrifugation. Activity is preserved after ether extraction and dialysis, but is 
lost after heating at 56°C and after treatment with activated papaln. A previous 
report indicated that the mycoplasmal extract was not affected by trypsin (5). 
The apparent difference in sensitivity to two proteolytic enzymes may be due 
to presence of trypsin inhibitors in the crude extract. 
The following data suggest that the lymphocyte inhibitor is arglnlne  deimin- 
ase, an enzyme known to account for as much as 10 % of the protein content 
of M. arthritidis  (15). All of the mycoplasma species that inhibit the response of 
lymphocytes to PHA require supplemental arginine  for growth. The addition 
of adequate  amounts of arginine  to medium containing  extract  restores the 
normal responsiveness  of the lymphocytes to PHA. Moreover, pretreatment of 
the medium with extract,  followed  by heat inactivation  of the latter,  yields 
medium in which the PHA reaction does not occur, but supplementation of this 
medium with arginine  restores the reaction. Finally, an arginase derived from 
S. faecalis caused s~milax inhibition of the PHA response  of lymphocytes and 
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antiserum against M. arthritidis caused inhibition of the extracts from all of the 
arginine  requiring mycoplasmas studied, indicating that the enzymes from all 
are closely related or identical,  but did not neutralize the streptococcal enzyme. 
The  capacity of  canavanine  to  inhibit  both  the  lymphocyte response  to 
PHA and the secondary immune response of lymph node fragments in vitro 
is consistent with the observed effect of mycoplasmal extracts. Canavanine is 
effective as a competitive analogue of arginine in other circumstances (21), and 
would be expected to mimic arginine  depletion in this system, except that its 
effect should be, and is, less reversible. 
Continued  synthesis of antibody at  somewhat reduced levels is noted in 
cultures which were treated for 6 days with mycoplasmal extracts after anti- 
genic stimulation and then washed to remove the extract. Similarly,  continuous 
immune globulin synthesis by a human lymphoid cell line is somewhat reduced, 
but not abolished. Rat hepatoma  cells, on the contrary,  continue unaltered 
levels of serum protein production in the presence of the mycoplasmal enzyme. 
These findings suggest that the memory cell for the immune response, the small 
lymphocyte, is dependent on exogenous arginine  for proliferation. Its progeny, 
however, like hepatoma cells, can continue to function in the absence of this 
amino acid.  This may be due to accumulated stores, decreased requirement for 
arginine,  or to formation of enzymes to synthesize the amino acid endogenously. 
The enzyme content of transformed cells is quantitatively and perhaps quali- 
tatively increased in comparison to the small  lymphocyte (29). 
The experiments with L-asparaginase  indicate that the action of arginase on 
lymphocytes cannot be regarded as unique. The mode of action of the E. coli 
enzyme remains in doubt since neither L-asparagine,  nor L-glutamine,  nor L- 
arginine  were capable of reversing its effect. However, it is dear  that arginine 
depletion is not involved in its inhibitory effect, and that  other enzymes may 
have a similar effect. 
The possibility exists that the observed effects of mycoplasmas on lympho- 
cytes may play a role in the pathogenesis of disease  caused by these agents, 
although no evidence bearing on the point was obtained in these studies. The 
failure to inhibit antibody formation in rats  and mice given repeated injections 
of extract is most likely due to failure to bring about sustained arginine  deple- 
tion for long enough periods in vivo. It may be that the situation in a localized 
infection with living mycoplasmas in close proximity to the surface of lympho- 
cytes, might well result  in interference with immune responsiveness.  Further 
studies on the effects of infection with live mycoplasmas are in progress. 
SUMMARY 
Extracts of five arginine-utilizing  mycoplasmas inhibit PHA-induced lympho- 
cyte  mitosis,  while  extracts  of  five  glucose-utilizing  mycoplasmas  do  not. 
Evidence is presented supporting  the view that  the inhibitory factor is the 
enzyme  arginine  deiminase.  This  enzyme  inhibits  the  reactions  of  human 1180  STUDIES OF  PPLO INFECTION. V 
lymphocytes to  antigens  as  well  as  PHA,  and  the  secondary production  of 
antibody by rabbit lymph node fragments in vitro. Addition of enzyme to the 
cells several days after the  initial mitotic or antigenic stimulus  reduces,  but 
does not abolish, further cellular activity. The production of serum proteins by 
hepatoma cells is totally unaffected by the mycoplasmal extract. It is concluded 
that arginine is an essential amino acid for the small lymphocyte, but not for 
the transformed cell nor for a number of other cell types. Suggestive evidence 
has been obtained  that  other enzymes similarly affect lymphocyte reactions. 
The authors would like to thank Mr. I. Rothman  and Dr. J. D. Broome for supplying 
Streptococcus faecMis at#nine deiminase and for assaying that enzyme in the mycoplasmal ex- 
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